Immix Biopharma Inc. (IMMX)
NASDAQ: IMMX
· Real-Time Price · USD
2.27
0.08 (3.65%)
At close: Aug 15, 2025, 3:59 PM
2.27
0.00%
After-hours: Aug 15, 2025, 04:27 PM EDT
Immix Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 96.29K | 96.29K | 96.29K | 4.78K | 4.78K | 4.78K | 4.78K | -89.52M | -89.52M | -89.52M | -89.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 164.92K | 109.38K | 74.05K | 77.13K | 52.6K | 28.81K | 5.47K | 2.96K | 2.14K | 2.02K | 2.13K | 2.19K | 2.24K | 1.86K | 1.85K | 1.23K | 1.19K | 1.19K |
Gross Profit | -116.78K | -61.24K | -25.91K | -72.34K | -47.82K | -24.03K | -684 | -89.52M | -89.52M | -89.52M | -89.52M | -2.19K | -2.24K | -1.86K | -1.85K | -1.23K | -1.19K | -1.19K |
Operating Income | -23.78M | -21.77M | -22.67M | -23.06M | -20.18M | -19.2M | -16.13M | -14.56M | -11.57M | -9.41M | -8.22M | -5.02M | -3.84M | -2.52M | -1.35M | -907.26K | -650.51K | -511.86K |
Interest Income | 696.81K | 899.66K | 1.02M | 1.06M | 990.09K | 812.02K | 572.01K | 343.43K | 156.74K | 27.89K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26.96K |
Pretax Income | -23.09M | -20.87M | -21.66M | -22M | -19.2M | -18.4M | -15.57M | -14.22M | -11.41M | -9.38M | -8.22M | -27.18M | -26.05M | -24.69M | -24.38M | -2.38M | -2.09M | -2.01M |
Net Income | -23.13M | -20.9M | -21.61M | -21.89M | -19.02M | -18.21M | -15.44M | -14.15M | -11.41M | -9.4M | -8.23M | -27.19M | -26.05M | -24.7M | -24.38M | -2.39M | -2.11M | -2.03M |
Selling & General & Admin | 12.02M | 11.75M | 11.4M | 10.05M | 9.52M | 8.55M | 7.4M | 6.66M | 5.08M | 4.52M | 4.02M | 3.08M | 2.56M | 1.79M | 1.23M | 706.64K | 434.62K | 298.8K |
Research & Development | 11.77M | 10.02M | 11.29M | 13.02M | 10.68M | 10.66M | 8.74M | 7.9M | 6.49M | 4.89M | 4.2M | 1.94M | 1.28M | 731.22K | 126.53K | 200.62K | 215.89K | 213.06K |
Other Expenses | -85.07K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6 | 2.00 | 2.00 |
Operating Expenses | 23.7M | 21.77M | 22.69M | 23.07M | 20.2M | 19.21M | 16.13M | 14.56M | 11.57M | 9.41M | 8.22M | 5.02M | 3.84M | 2.52M | 1.35M | 907.26K | 650.51K | 511.6K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 497.00 | 497.00 | 606.00 | 994.00 | 45K | 98.94K | 152.7K | 179.85K | 160.04K | 129.47K | 75.61K |
Selling & Marketing Expenses | n/a | n/a | 14.33K | 3.89K | 3.89K | 3.89K | -10.44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 23.78M | 21.77M | 22.67M | 23.06M | 20.18M | 19.2M | 16.13M | 14.56M | 11.57M | 9.41M | 8.22M | 5.02M | 3.84M | 2.52M | 1.35M | 907.26K | 650.51K | 511.6K |
Income Tax Expense | 40.66K | 42.02K | 41.04K | 38.34K | 34K | 30.08K | 26.41K | 23.59K | 18.45K | 13.82K | 10.27K | 6.49K | 6.15K | 6.04K | 6.01K | 16.83K | 17.21K | 17.37K |
Shares Outstanding (Basic) | 29.98M | 29.7M | 27.54M | 29.42M | 28.79M | 23.44M | 19.92M | 18.58M | 15.04M | 13.9M | 13.23M | 13.92M | 13.88M | 13.83M | 7.58M | 7.2M | 8.77M | 8.77M |
Shares Outstanding (Diluted) | 29.98M | 29.7M | 27.54M | 29.42M | 28.79M | 23.44M | 19.92M | 18.58M | 15.04M | 13.9M | 13.23M | 13.92M | 13.88M | 13.83M | 7.58M | 7.2M | 8.77M | 8.77M |
EPS (Basic) | -0.78 | -0.71 | -0.78 | -0.87 | -0.86 | -0.95 | -0.91 | -0.94 | -0.82 | -0.69 | -0.61 | -3.32 | -3.26 | -3.18 | -3.2 | -0.3 | -0.26 | -0.27 |
EPS (Diluted) | -0.78 | -0.71 | -0.78 | -0.87 | -0.86 | -0.95 | -0.91 | -0.94 | -0.82 | -0.69 | -0.61 | -3.32 | -3.26 | -3.18 | -3.2 | -0.3 | -0.26 | -0.27 |
EBITDA | -23.72M | -21.68M | -22.58M | -22.78M | -19.75M | -18.79M | -15.72M | -14.37M | -11.57M | -9.41M | -8.22M | -27.13M | -25.95M | -24.54M | -24.2M | -2.21M | -1.96M | -1.91M |
EBIT | -23.68M | -21.77M | -22.67M | -22.83M | -19.78M | -18.8M | -15.73M | -14.37M | -11.57M | -9.41M | -8.22M | -27.13M | -25.95M | -24.54M | -24.2M | -2.22M | -1.96M | -1.91M |
Depreciation & Amortization | 126.42K | 150.72K | 115.39K | 77.13K | 52.6K | 28.81K | 5.47K | 2.96K | 2.14K | 2.02K | 2.13K | 2.19K | 2.24K | 2.48K | 2.47K | 2.43K | 2.39K | 2.35K |